MAPT and tauopathy: In addition, given the complex temporal trajectories of brain myeloid responses in tauopathy [107], future research on large cohorts of presymptomatic MAPT pathogenic variant carriers will be needed to determine which peripheral changes observed here occur prior to disease onset.